Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Autoimmune Polyendocrine Syndrome Complicated by Pulmonary Hypertension

Author(s): Olga E. Disoteo, Benedetta Zampetti, Andrea Garascia, Roberto Attanasio* and Renato Cozzi

Volume 21, Issue 3, 2021

Published on: 31 July, 2020

Page: [561 - 565] Pages: 5

DOI: 10.2174/1871530320666200801033106

Price: $65

Abstract

A 24-years old female was admitted for acute renal failure, melanoderma, hyponatremia, and hyperkalemia. The clinical suspicion of Addison’s disease was confirmed by laboratory test and the appropriate replacement therapy with corticosteroids and fludrocortisone was started. In the meantime primary hypothyroidism and diabetes mellitus type 1 were disclosed and treated, thus fulfilling a diagnosis of autoimmune polyendocrine syndrome type 2. Eighteen months later she was admitted for right-sided heart failure. The work-up allowed to diagnose pulmonary arterial hypertension. Here, we report the clinical course and discuss the putative link between these two rare diseases.

Keywords: Autoimmune polyendocrine syndrome, pulmonary arterial hypertension, hypothyroidism, hypoadrenalism, diabetes mellitus.

« Previous
[1]
Neufeld, M.; Blizzard, R.M. Polyglandular autoimmune diseases.Symposium on autoimmune aspects of endocrine disorders., 1980, pp. 357-365.
[2]
Husebye, E.S.; Perheentupa, J.; Rautemaa, R.; Kämpe, O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med., 2009, 265(5), 514-529.
[http://dx.doi.org/10.1111/j.1365-2796.2009.02090.x] [PMID: 19382991]
[3]
Betterle, C.; Dal Pra, C.; Mantero, F.; Zanchetta, R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev., 2002, 23(3), 327-364.
[http://dx.doi.org/10.1210/edrv.23.3.0466]
[4]
Betterle, C.; Presotto, F. Autoimmune polyendocrine syndromes (APS) or multiple autoimmune syndromes (MAS). Handbook of systemic autoimmune diseases. Endocrine Manifestations of Autoimmune diseases; Walker, SE; Jara, LJ, Eds.; Elseviers Publisher, 2008; Vol. 9, pp. 135-148;
[5]
Kahaly, G.J. Polyglandular autoimmune syndromes. Eur. J. Endocrinol., 2009, 161(1), 11-20.
[http://dx.doi.org/10.1530/EJE-09-0044] [PMID: 19411300]
[6]
Betterle, C.; Scarpa, R.; Garelli, S.; Morlin, L.; Lazzarotto, F.; Presotto, F.; Coco, G.; Masiero, S.; Parolo, A.; Albergoni, M.P.; Favero, R.; Barollo, S.; Salvà, M.; Basso, D.; Chen, S.; Rees Smith, B.; Furmaniak, J.; Mantero, F. Addison’s disease: a survey on 633 patients in Padova. Eur. J. Endocrinol., 2013, 169(6), 773-784.
[http://dx.doi.org/10.1530/EJE-13-0528] [PMID: 24014553]
[7]
Simonneau, G.; Montani, D.; Celermajer, D.S.; Denton, C.P.; Gatzoulis, M.A.; Krowka, M.; Williams, P.G.; Souza, R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J., 2019, 53(1)1801913
[http://dx.doi.org/10.1183/13993003.01913-2018] [PMID: 30545968]
[8]
Galiè, N.; Humbert, M.; Vachiery, J.L.; Gibbs, S.; Lang, I.; Torbicki, A.; Simonneau, G.; Peacock, A.; Vonk Noordegraaf, A.; Beghetti, M.; Ghofrani, A.; Gomez Sanchez, M.A.; Hansmann, G.; Klepetko, W.; Lancellotti, P.; Matucci, M.; McDonagh, T.; Pierard, L.A.; Trindade, P.T.; Zompatori, M.; Hoeper, M. ESC Scientific Document Group.2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J., 2016, 37(1), 67-119.
[http://dx.doi.org/10.1093/eurheartj/ehv317] [PMID: 26320113]
[9]
Huertas, A.; Perros, F.; Tu, L.; Cohen-Kaminsky, S.; Montani, D.; Dorfmüller, P.; Guignabert, C.; Humbert, M. Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay. Circulation, 2014, 129(12), 1332-1340.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.113.004555] [PMID: 24664216]
[10]
Marvisi, M.; Balzarini, L.; Mancini, C.; Mouzakiti, P. Thyroid gland and pulmonary hypertension. What’s the link? Panminerva Med., 2013, 55(1), 93-97.
[PMID: 23474667]
[11]
Scicchitano, P.; Dentamaro, I.; Tunzi, F.; Ricci, G.; Carbonara, S.; Devito, F.; Zito, A.; Ciampolillo, A.; Ciccone, M.M. Pulmonary hypertension in thyroid diseases. Endocrine, 2016, 54(3), 578-587.
[http://dx.doi.org/10.1007/s12020-016-0923-8] [PMID: 26994930]
[12]
Chu, J.W.; Kao, P.N.; Faul, J.L.; Doyle, R.L. High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest, 2002, 122(5), 1668-1673.
[http://dx.doi.org/10.1378/chest.122.5.1668] [PMID: 12426269]
[13]
Li, J.H.; Safford, R.E.; Aduen, J.F.; Heckman, M.G.; Crook, J.E.; Burger, C.D. Pulmonary hypertension and thyroid disease. Chest, 2007, 132(3), 793-797.
[http://dx.doi.org/10.1378/chest.07-0366] [PMID: 17646226]
[14]
Sweeney, L.; Voelkel, N.F. Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension. Eur. J. Med. Res., 2009, 14(10), 433-442.
[http://dx.doi.org/10.1186/2047-783X-14-10-433] [PMID: 19748850]
[15]
Hostiuc, M.; Curca, G.C.; Dermengiu, D.; Sinescu, C.; Hostiuc, S. Can subclinical hypothyroidism explain some sudden deaths due to pulmonary embolism without evident risk factors? Med. Hypotheses, 2011, 76(6), 855-857.
[http://dx.doi.org/10.1016/j.mehy.2011.02.035] [PMID: 21420793]
[16]
Erem, C.; Ucuncu, O.; Yilmaz, M.; Kocak, M.; Nuhoglu, I.; Ersoz, H.O. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine, 2009, 35(1), 75-80.
[http://dx.doi.org/10.1007/s12020-008-9116-4] [PMID: 18958631]
[17]
Taddei, S.; Caraccio, N.; Virdis, A.; Dardano, A.; Versari, D.; Ghiadoni, L.; Ferrannini, E.; Salvetti, A.; Monzani, F. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab., 2006, 91(12), 5076-5082.
[http://dx.doi.org/10.1210/jc.2006-1075] [PMID: 16968790]
[18]
Topaloglu, O.; Gokay, F.; Kucukler, K.; Burnik, F.S.; Mete, T.; Yavuz, H.C.; Berker, D.; Guler, S. Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status? Endocrine, 2013, 44(1), 145-151.
[http://dx.doi.org/10.1007/s12020-012-9842-5] [PMID: 23184180]
[19]
McLeod, D.S. Autoimmune thyroid disease: a novel risk factor for atherosclerosis? Endocrine, 2013, 44(1), 8-10.
[http://dx.doi.org/10.1007/s12020-013-9952-8] [PMID: 23579639]
[20]
Badesch, D.B.; Wynne, K.M.; Bonvallet, S.; Voelkel, N.F.; Ridgway, C.; Groves, B.M. Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann. Intern. Med., 1993, 119(1), 44-46.
[http://dx.doi.org/10.7326/0003-4819-119-1-199307010-00008] [PMID: 8498763]
[21]
Arroliga, A.C.; Dweik, R.A.; Rafanan, A.L. Primary pulmonary hypertension and thyroid disease. Chest, 2000, 118(4), 1224-1225.
[http://dx.doi.org/10.1378/chest.118.4.1224] [PMID: 11035704]
[22]
Ferris, A.; Jacobs, T.; Widlitz, A.; Barst, R.J.; Morse, J.H. Pulmonary arterial hypertension and thyroid disease. Chest, 2001, 119(6), 1980-1981.
[http://dx.doi.org/10.1378/chest.119.6.1980] [PMID: 11399743]
[23]
Sahin, M.; Sade, L.E.; Tutuncu, N.B.; Gursoy, A.; Kebapcilar, L.; Muderrisoglu, H.; Guvener, N.D. Systolic pulmonary artery pressure and echocardiographic measurements in patients with euthyroid Hashimoto’s thyroiditis. J. Endocrinol. Invest., 2009, 32(6), 530-532.
[http://dx.doi.org/10.1007/BF03346501] [PMID: 19474524]
[24]
Vargas, F.; Moreno, J.M.; Rodriguez-Gomez, I.; Wangensteen, R.; Osuna, A.; Alvarez-Guerra, M.; Garcia-Estan, J. Vascular and renal function in experimental thyroid disorders. Eur. J. Endocrinol., 2006, 154(2), 197-212.
[http://dx.doi.org/10.1530/eje.1.02093]
[25]
Klein, I.; Danzi, S. Thyroid disease and the heart. Circulation, 2007, 116, 1725-1735.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.678326]
[26]
Araz, O.; Yilmazel Ucar, E.; Yalcin, A.; Pulur, D.; Acemoglu, H.; Tas, H.; Saglam, L.; Akgun, M.; Mirici, A. The incidence and severity of pulmonary hypertension in obstructive sleep apnea with hypothyroidism. Med. Sci. Monit., 2013, 19, 883-887.
[http://dx.doi.org/10.12659/MSM.889619] [PMID: 24149072]
[27]
Barrou, Z.; Pehuet-Figoni, M.; Weber, S.; Lockhart, A.; Luton, J.P. Polyendocrinopathy combined with primary pulmonary arterial hypertension Presse Med., 1989, 18(19), 963-965.
[PMID: 2525720]
[28]
García-Hernández, F.J.; Ocaña-Medina, C.; González-León, R.; Garrido-Rasco, R.; Sánchez-Román, J. Autoimmune polyglandular syndrome and pulmonary arterial hypertension. Eur. Respir. J., 2006, 27(3), 657-658.
[http://dx.doi.org/10.1183/09031936.06.00133505] [PMID: 16507873]
[29]
Saliba, W.R.; Rock, W.; Elias, M. Pulmonary hypertension in a patient with Schmidt syndrome. Am. J. Emerg. Med., 2009, 27(8), 1025.e1-2.
[http://dx.doi.org/10.1016/j.ajem.2008.12.040] [PMID: 9857444]

Rights & Permissions Print Cite
Article Metrics
17
1
© 2024 Bentham Science Publishers | Privacy Policy